Overview

Axillary Lymph Node Preservation Surgery in Reducing Lymphedema in Patients With Breast Cancer

Status:
Terminated
Trial end date:
2014-05-01
Target enrollment:
0
Participant gender:
Female
Summary
This pilot phase I and randomized phase II trial studies the best way to perform axillary lymph node preservation surgery and to see how well it works in preventing lymphedema in patients with breast cancer. Lymph node mapping may help in planning surgery to remove breast cancer and affected lymph nodes. It is not yet known whether reverse mapping guided axillary lymph node dissection is more effective than standard axillary lymph node dissection in preventing lymphedema.
Phase:
Phase 1/Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
City of Hope Medical Center
Collaborator:
National Cancer Institute (NCI)
Criteria
Inclusion Criteria:

- Patients diagnosed with breast cancer with a planned axillary lymph node dissection
planned for breast cancer

Exclusion Criteria:

- Prior lymphedema in either arm

- Prior history of axillary surgery (except for sentinel node biopsies)

- Prior history of chest/axillary radiation

- Need for bilateral axillary node dissection surgery

- Prior neurologic deficits (either motor or sensory) in ipsilateral arm

- Known allergy to vital blue dyes

- No prior diagnosis of inflammatory breast cancer

- Cannot be pregnant or planning to continue breast-feeding immediately after surgery